Search
Stiripentol
go.drugbank.com/drugs/DB09118ApprovedInvestigational[A19740, A250825] The clinical development and marketing of stiripentol were first delayed due to the drug's potent inhibitory effects on hepatic cytochrome P450 (CYP) enzymes.
Categories: Cytochrome P-450 CYP1A2 Inducers, P-glycoprotein inhibitorsCeftobiprole medocaril
go.drugbank.com/drugs/DB14733ApprovedMedicinal Products for Human Use (CHMP) adopted a negative opinion of ceftobiprole medocaril in February 2010, recommending the refusal of its marketing authorization in the European Union primarily due
Calcium lactate gluconate
go.drugbank.com/drugs/DB13365InvestigationalMixtures: Calcium Vitamin D3 STELLA Effervescent tabletEnzalutamide d3
go.drugbank.com/drugs/DB19123InvestigationalEnzalutamide d3 is under investigation in clinical trial NCT03850795 (HC-1119 Versus Enzalutamide in Metastatic Castration-resistant Prostate Cancer (Mcrpc)).
Synonyms: Enzalutamide d3, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-n-(methyl-d3)benzamide1alpha-Hydroxyvitamin D5
go.drugbank.com/drugs/DB13097Investigational1alpha-Hydroxyvitamin D5 (CARD-024) has been used in trials studying the treatment of Drug Safety and Heart; Disease, Activity.
Synonyms: 1-Hydroxyvitamin D5Categories: Vitamin D and AnaloguesMipicoledine
go.drugbank.com/drugs/DB15075InvestigationalMipicoledine is under investigation in clinical trial NCT01048008 (Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer).
Synonyms: DM-CHOC-PENCategories: P-glycoprotein substratesBoron
go.drugbank.com/drugs/DB11203ApprovedInvestigationalNatural boron exists in 2 stable isotopes however pure boron is hard to prepare due to contamination by different elements.
Mixtures: Calcium Folic Acid Plus D ChewableRaloxifene
go.drugbank.com/drugs/DB00481ApprovedInvestigationalDue to the decline in estrogen levels in postmenopausal osteoporosis, hormone replacement therapy (HRT), such as estradiol, has been used to ameliorate the condition. … Due to the risk of bone fractures that may lead to morbidities and reduced quality of life, the management of osteoporosis in postmenopausal women with the use of therapeutic agents in addition to concurrent
Categories: P-glycoprotein substrates, Cytochrome P-450 CYP2B6 InhibitorsPlazinemdor
go.drugbank.com/drugs/DB21493InvestigationalPlazinemdor has a monoisotopic molecular weight of 432.12 Da.
Tirfipiravir
go.drugbank.com/drugs/DB21648ExperimentalTirfipiravir has a monoisotopic molecular weight of 355.1 Da.